在SLC6A1相关的神经发育障碍中治疗耐药性的辅助阿扎胺:一个探索性病例系列
Gia Melikishvili1, Olivier Dulac2, Otar Koniashvili1,3
1MediClubGeorgia Medical Center, Tbilisi, Georgia.
Epilepsia open
|October 24, 2025
概括
乙醇胺 (ACZ) 显示为治疗与SLC6A1相关的神经发育障碍的儿童耐药性发作的前景. 辅助ACZ治疗在一小群患者中改善了控制和神经症状.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在SLC6A1基因的致病变体与神经发育障碍 (SLC6A1-NDD) 相关,其特点是发育迟缓,行为问题,耐药性和.
- 具有类似临床表现的疾病,如SLC2A1,CHD2和CACNA1A疾病,已对乙胺 (ACZ) 治疗产生积极反应.
研究的目的:
- 评估乙胺 (ACZ) 作为辅助疗法的疗效,用于治疗被诊断患有SLC6A1相关神经发育障碍 (SLC6A1-NDD) 的患者的抗药性发作.
- 评估ACZ对这种患者群体中发作频率,严重程度,性衰竭和社交互动的影响.
主要方法:
- 对六名具有遗传确认致病性SLC6A1变体和抗药性发作患者的医疗记录的回顾性审查,这些患者接受了额外的ACZ治疗.
- 根据临床判断和护理人员报告,评估发作频率和严重程度的变化,不良事件以及动力衰竭和社交互动的改善.
- 在平均持续时间为30个月后,平均ACZ剂量为16.2 mg/kg/天后,对治疗结果的分析.
主要成果:
- 六分之三的患者 (50%) 实现了完全的缓解.
- 其余三名患者的发作频率减少了50-90%.
- 在四名患者中,有三名患者观察到过敏症的改善,在六名患者中,有五名患者报告了增强的社交互动和学校参与. 一名患者轻微减肥,没有其他严重不良事件.
结论:
- 乙胺 (ACZ) 显示出作为SLC6A1相关神经发育障碍 (SLC6A1-NDD) 中耐药发作的安全有效辅助治疗的潜力.
- 此外,ACZ也可能对和行为症状产生积极影响,这表明它具有更广泛的治疗效益.
- 需要进一步的前性研究,使用更大的队列和标准化结果措施,以确认ACZ对SLC6A1-NDD的疗效和长期安全性.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
814
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
01:14Antiepileptic Drugs: Glutamate Antagonists
888
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
888
01:20Antiepileptic Drugs: Potassium Channel Activators
631
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
631
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K